Genocea Biosciences reported $-14175000 in EBITDA for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agenus AGEN:US $ -64.67M 25.03M
Baxter International BAX:US $ 698M 45M
Bluebird Bio BLUE:US $ -234.8M 9.32M
Cytokinetics CYTK:US $ -54.25M 14.18M
Cytori Therapeutics CYTX:US $ -2.48M 0.09M
Genocea Biosciences GNCA:US $ -14.18M 2.13M
Glaxosmithkline GSK:US $ 2626M 584M
Mirati Therapeutics MRTX:US $ -163.78M 31.65M
Moderna Inc MRNA:US 3.13B 1.85B
Novavax NVAX:US $ -343.42M 137.1M
Pfizer PFE:US $ 7593M 610M
Prothena PRTA:US 28.24M 60.04M